Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.
Discover how the differentiation status of nonactivated CAR T cells can improve therapeutic efficacy of cancer immunotherapy. In this webinar, the University of Pennsylvania’s Dr. Saba Ghassemi, will discuss strategies for enhanced CAR T cell persistence and function, for better, more durable anti-tumor responses. She will explore how metabolic engineering strategies and cytokine expression can enhance CAR T cell survival, persistence, and function in challenging conditions such as the tumor microenvironment.
Attend this webinar to learn about tools that provide deep insights into CAR T cell potency via real-time, label-free tracking of tumor killing. Additionally, discover how nonactivated CAR T cells can improve CAR T longevity and therapeutic efficacy.
Attend this webinar to learn about: